Obesity, disease burden, and prescription spending by community-dwelling Medicare beneficiaries

Current Medical Research and Opinion

Volumn 24, Issue 8, 2008, Pages 2377-2387

  Stuart, Bruce ^a   Lloyd, Jennifer ^a   Zhao, Lirong ^a   Kamal Bahl, Sachin ^b  

^a UNIVERSITY OF MARYLAND SCHOOL OF PHARMACY   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Chronic disease; Drug spending; Medicare; Obesity; Prescription drugs

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; NITRATE; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; ORAL ANTIDIABETIC AGENT; VASODILATOR AGENT;

ADULT; AGED; ASTHMA; BODY MASS; CHRONIC DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; COMMUNITY CARE; COMMUNITY LIVING; COMORBIDITY; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DRUG COST; DRUG UTILIZATION; FEMALE; HEALTH CARE COST; HEALTH STATUS; HEART FAILURE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICARE; OBESITY; OSTEOARTHRITIS; POPULATION RESEARCH; PRESCRIPTION; PREVALENCE; REVIEW;

BODY MASS INDEX; CHRONIC DISEASE; DRUG COSTS; DRUG UTILIZATION REVIEW; HUMANS; MEDICARE; OBESITY; UNITED STATES;

EID: 50149107384     PISSN: 03007995     EISSN: None     Source Type: Journal    
DOI: 10.1185/03007990802262275     Document Type: Review

References (22)

1. Medicare Payment Advisory Commission. Report to the Congress: Promoting Greater Efficiency in Medicare. June 2007. Available at: www.medpac.gov/ documents/Jun07-EntireReport.pdf. Accessed October 26, 2007
2. Arterburn DE, Crane PK, Sullivan SD. The coming epidemic of obesity in elderly Americans. J Am Geriatr Soc 2004;52:1907-12
3. Doshi JA, Polsky D, Chang VW. Prevalence and trends in obesity among aged and disabled U.S. Medicare beneficiaries, 1997-2002. Health Aff (Millwood) 2007;26:1111-17
4. Must A, Spadano J, Coakley EH, et al. The disease burden associated with overweight and obesity. JAMA 1999;282:1523-9
5. Thorpe KE. Factors accounting for the rise in health-care spending in the United States: the role of rising disease prevalence and treatment intensity. Public Health 2006;120:1002-7
6. Thompson D, Brown JB, Nichols GA, et al. Body mass index and future healthcare costs: a retrospective cohort study. Obes Res 2001;9:210-18
7. Andreyeva T, Sturm R, Ringel JS. Moderate and severe obesity have large differences in health care costs. Obes Res 2004; 12:1936-43
8. Lakdawalla DN, Goldman DP, Shang B. The health and cost consequences of obesity among the future elderly. Health Aff (Millwood) 2005;24(Suppl 2):30-41
9. Finkelstein EA, Fiebelkorn IC, Wang G. National medical spending attributable to overweight and obesity: how much, and who's paying? Health Aff (Millwood) 2003;W3:219-26
10. Counterweight Project Team. The impact of obesity on drug prescribing in primary care. Br J Gen Pract 2005.55:743-9
11. Reidpath DD, Crawford D, Tilgner L, et al. Relationship between body mass index and the use of healthcare services in Australia. Obes Res 2002;10:526-31
12. van Dijk L, Otters HB, Schuit AJ. Moderately overweight and obese patients in general practice: a population based survey. BMC Fam. Pract 2006;7:43
13. Quesenberry CP, Jr, Caan B, Jacobson A. Obesity, health services use, and health care costs among members of a health maintenance organization. Arch Intern Med 1998;158:466-72
14. Sturm R. The effects of obesity, smoking, and drinking on medical problems and costs. Health Aff (Millwood) 2002; 21:245-53
15. Adler GS. A profile of the Medicare current beneficiary survey. Health Care Financ Rev 1994;15:153-63
16. Buntin MB, Zaslavsky AM. Too much ado about two-part models and transformation? Comparing methods of modeling Medicare expenditures. J Health Econ 2004;23:525-42
17. Ogden CL, Carroll MD, Curtin LR, et al. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 2006;295:1549-55
18. Kuczmarski MF, Kuczmarski RJ, Najjar M. Effects of age on validity of self-reported height, weight, and body mass index: Findings from the third national health and nutrition examination survey, 1988-1994. J Am Diet Assoc 2001;101:28-34; quiz 35-6
19. Sorkin J, Muller D, Andres R. Longitudinal change in height of men and women: implications for interpretation of the body mass index. Am J Epidemiol 1999;150(9):969-77
20. Roubenoff R. The pathophysiology of wasting in the elderly. J Nutr 1999;129:256-9S
21. Seidell JC, Visscher TL. Body weight and weight change and their health implications for the elderly. Eur J Clin Nutr 2000;54(Suppl 3):S33-9
22. Poisal J. Reporting of drug expenditures in the MCBS. Health Care Financ Rev 2003;25(2):23-36